← Back to Search

A1Control App for Diabetes Management in Youth

N/A

Recruiting

Research Sponsored by Ohio State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 4, 8, and 12 weeks

Awards & highlights

Study Summary

This trial will test a diabetes app to help youth manage their diabetes better in their own homes.

Who is the study for?

This trial is for young people aged 10-18 with type 1 diabetes for over a year, who are already using an insulin pump or hybrid closed-loop therapy for at least six months. It's not suitable for those with significant learning disabilities, pregnant individuals, or those unable to read and write in English.Check my eligibility

What is being tested?

The study is testing the use of a mobile health (mHealth) app designed to educate youth on diabetes technology. Participants will use this app at home over a period of 12 weeks to see how feasible and helpful it is.See study design

What are the potential side effects?

Since this trial involves an educational application rather than medication, traditional side effects are not applicable. However, participants may experience issues related to app usability or challenges integrating the tool into daily life.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 4, 8, and 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 4, 8, and 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4, 8, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Measure of Engagement in Personal Healthcare

Secondary outcome measures

Glycemic control

Trial Design

1Treatment groups

Experimental Treatment

Group I: All ParticipantsExperimental Treatment1 Intervention

All participants will perform the same study activities

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor

830 Previous Clinical Trials

505,600 Total Patients Enrolled

Media Library

All Participants Clinical Trial Eligibility Overview. Trial Name: NCT05953532 — N/A

Patient Engagement Research Study Groups: All Participants

Patient Engagement Clinical Trial 2023: All Participants Highlights & Side Effects. Trial Name: NCT05953532 — N/A

All Participants 2023 Treatment Timeline for Medical Study. Trial Name: NCT05953532 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the eligibility criteria for this trial limited to individuals over 60 years of age?

"This trial's requirements for participation state that individuals must be between 10 and 18 years old."

Answered by AI

Are there any remaining opportunities to join this trial?

"According to clinicaltrials.gov, the recruitment for this trial has been concluded. The study was initially posted on November 1st 2023 and had its last update on July 12th 2023. At present there are 24 other medical studies that remain open for enrollment of participants."

Answered by AI

What criteria must participants meet in order to be eligible for this trial?

"To be considered for this medical trial, participants should demonstrate a readiness to engage with the study as well as fall between the age bracket of 10 and 18 years old. This research is aiming to accept 20 patients in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Developing a mHealth Simulation Platform for Youth

2023. "Developing a mHealth Simulation Platform for Youth". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05953532.